X4 Pharmaceuticals, Inc. 2024 Q3 – Results – Earnings Call Presentation (NASDAQ:XFOR)


Q3: 2024-11-13 Earnings Summary

EPS of -$0.18 misses by $0.01 | Revenue of $560.00K misses by $1.13M

This article was written by

Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and are continuing to grow and expand our coverage. The purpose of this profile is to allow us to share with our readers new transcript-related developments. Thanks, SA Transcripts Team



Source link

Leave a Comment

Your email address will not be published. Required fields are marked *